These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39223664)

  • 21. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
    Miao Y; Meng H
    Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons.
    Luo J; Sun L; Lin X; Liu G; Yu J; Parisiadou L; Xie C; Ding J; Cai H
    Hum Mol Genet; 2014 Dec; 23(24):6567-74. PubMed ID: 25051958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
    Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
    Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
    Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
    Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.
    Gegg ME; Verona G; Schapira AHV
    Hum Mol Genet; 2020 Jun; 29(10):1716-1728. PubMed ID: 32391886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice.
    Challis C; Hori A; Sampson TR; Yoo BB; Challis RC; Hamilton AM; Mazmanian SK; Volpicelli-Daley LA; Gradinaru V
    Nat Neurosci; 2020 Mar; 23(3):327-336. PubMed ID: 32066981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of phosphorylated α-synuclein in Macaca fuscata.
    Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M
    Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrastriatal injection of Parkinson's disease intestine and vagus lysates initiates α-synucleinopathy in rat brain.
    Yang Z; Wang Y; Wei M; Li S; Jia C; Cheng C; Al-Nusaif M; Zhang J; Liu C; Le W
    Cell Death Dis; 2023 Jan; 14(1):4. PubMed ID: 36604420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
    Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
    Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice.
    Zhang J; Park ES; Park HJ; Yan R; Grudniewska M; Zhang X; Oh S; Yang X; Baum J; Mouradian MM
    Neurobiol Aging; 2020 Jan; 85():49-57. PubMed ID: 31734439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation.
    Tavassoly O; Del Cid Pellitero E; Larroquette F; Cai E; Thomas RA; Soubannier V; Luo W; Durcan TM; Fon EA
    Neurotherapeutics; 2021 Apr; 18(2):979-997. PubMed ID: 33713002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.
    Kulkarni AS; Del Mar Cortijo M; Roberts ER; Suggs TL; Stover HB; Pena-Bravo JI; Steiner JA; Luk KC; Brundin P; Wesson DW
    J Parkinsons Dis; 2020; 10(4):1411-1427. PubMed ID: 32925105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
    Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.
    Butler YR; Liu Y; Kumbhar R; Zhao P; Gadhave K; Wang N; Li Y; Mao X; Wang W
    Nat Commun; 2022 Jul; 13(1):4060. PubMed ID: 35853942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
    Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
    Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
    Tavassoly O; Yue J; Vocadlo DJ
    FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
    Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.